David Scheer

David I.
Scheer was the founder of Scheer & Co., Inc. (founded 1981) serving as President; Optherion, Inc. (founded 2005) serving as Chairman in 2010; OraPharma, Inc. (founded 1996) serving as Director in 2003; Esperion Therapeutics, Inc. (founded 1998) serving as Director from 1998 to 2003; Tengion, Inc. (founded 2003) serving as Chairman from 2011 to 2014; Aegerion Pharmaceuticals, Inc. (founded 2005) serving as Independent Director from 2016 to 2018; and Sopherion Therapeutics LLC (founded 2001) serving as Director.
Current jobs include Vice Chairman & Secretary at Global Virus Network since 2022, Chairman at Arrett Neuroscience, Inc., Director-Biomedical & Interventional Technologies at Yale University, Director at Connecticut United for Research Excellence, Inc. since 2007, and Member at NYU Langone Health.
Former jobs include Chairman at Renetx Bio, Inc. from 2009 to 2017, Chairman at Angiochem, Inc. from 2014 to 2016, Vice Chairman at Long Wharf Theatre from 2012 to 2013, Director at Shire ViroPharma, Inc. from 1994 to 1997, Director at Achillion Pharmaceuticals, Inc. from 2019 to 2020, and Member-Leadership Council at Harvard T.H.
Chan School of Public Health.
Education includes graduate studies at Yale University and undergraduate studies at Harvard College.